Trial Profile
A Retrospective Study Of Bacterial Endophthalmitis outbreak following intravitreal injection of bevacizumab in patients from Iran
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Age-related macular degeneration; Diabetic macular oedema; Diabetic retinopathy; Retinal vein occlusion
- Focus Adverse reactions; Therapeutic Use
- 17 Apr 2017 New trial record